Eric Slosberg Email

Co-Founder, Chief Development Officer, Head Research and Development . OnCusp Therapeutics

Current Roles

Employees:
24
Revenue:
$4.8M
About
OnCusp Therapeutics, Inc., headquartered in New York City, is a biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validated treatments for cancer patients worldwide. OnCusp was co-founded by Dr. Bing Yuan, Dr. Eric Slosberg, and Dr. Andy Fu, and has built a strong team of accomplished veterans with proven track records in building startup biotechs, leading successful preclinical and clinical programs, and creating value through global partnerships. The company is committed to accelerating the advancement of globally competitive oncology assets for patients.
OnCusp Therapeutics Address

New York, NY
United States
OnCusp Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.